News about genomics analysis tools including next generation sequencing, electrophoresis, PCR, and others
Canopy Biosciences launches CRISPR Complete Gene Editing Kits ST. LOUIS, Nov. 13, 2017 /PRNewswire/ — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene... Read more
Published on November 13, 2017. Groundbreaking nucleic acid detection technology using nanomaterials DUESSELDORF, Germany, November 13 – GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR® platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair... Read more
SnapGene customers can now order synthetic biology constructs directly from the software through Synbio Technologies. November 13, 2017 07:00 AM Pacific Standard Time CHICAGO–(BUSINESS WIRE)–Synbio Technologies and GSL Biotech have finalized a non-exclusive agreement allowing customers of GSL Biotech’s “SnapGene” software to order constructs directly from Synbio Technologies after having designed them in SnapGene. GSL Biotech developed SnapGene... Read more
DUBLIN, Ireland, and Mountain View, CA, November 10, 2017 – ERS Genomics Ltd. and Cellecta, Inc. announced today a non-exclusive license agreement to provide Cellecta with worldwide access to ERS Genomics’ CRISPR/Cas9 genome editing intellectual property for use in informing research tools and services. ERS Genomics holds rights to the foundational CRISPR/Cas9 patent portfolio from Dr. Emmanuelle Charpentier, who... Read more
Lexogen and Bluebee launch SLAMdunk data analysis pipeline RIJSWIJK, The Netherlands and Vienna, Austria — November 10, 2017 — Bluebee, a company driving genomic data-driven medicine, and Lexogen a company enabling the analysis of the complete transcriptome, announce the successful integration of the SLAMdunk pipeline on Bluebee’s private cloud-based platform, making it available to analyze data generated by... Read more
SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) announced today that Gary S. Guthart will join the company’s Board of Directors on December 1, 2017. Dr. Guthart is President and Chief Executive Officer of Intuitive Surgical, a global leader in the field of robotic-assisted minimally invasive surgery. Dr. Guthart joined Intuitive Surgical in April 1996 and has served... Read more
Novel single-tube enzymatic fragmentation technology simplifies library preparation, minimizing sample loss Ipswich, MA, USA (November 7, 2017) — New England Biolabs (NEB®) today announced the release of the NEBNext Ultra II FS DNA Library Prep Kit for next generation sequencing (NGS). This new kit employs a novel enzymatic fragmentation system that combines fragmentation, end repair and... Read more
November 6, 2017 Consortium will build cloud-based data resources, tools, and interoperable standards, giving researchers simultaneous access to biomedical datasets from across the National Institutes of Health CAMBRIDGE, Mass., November 06, 2017 – Seven Bridges, the leading biomedical data analysis company, today announced that it has been selected by the National Institutes of Health (NIH) to support... Read more
November 03, 2017 07:45 AM Pacific Daylight Time WOBURN, Mass.–(BUSINESS WIRE)–SeqLL, LLC announced today that it has installed a true Single Molecule Sequencing (tSMS) Instrument at the Harvard-MGH Cancer Center to support oncology research conducted by Dr. David Ting, MD. Dr. Ting is Assistant Professor of Medicine at Harvard Medical School and a medical oncologist... Read more
MENLO PARK, Calif., Nov. 02, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:PACB) announced today that Kathy Ordoñez has been named Chief Commercial Officer and Executive Vice President. Ms. Ordoñez brings more than thirty years of experience in the life sciences and diagnostics industries, with senior roles at Hoffmann-La Roche, Celera, Quest Diagnostics and... Read more